Priyanka(Surana)SharmaMD

Oncology • Fairway, KS

Breast Cancer, Hematologic Oncology

Associate Professor of Medicine, Department of Internal Medicine

Join to view full profile

Dr. Sharma is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Sharma's full profile

Already have an account?

Office
2650 Shawnee Mission Pkwy
Fairway, KS 66205
Phone+1 913-588-4085

Fax+1 913-588-9822
Is this information wrong?

Education & Training

University of Kansas School of MedicineFellowship, Hematology and Medical Oncology, 2002 - 2005
University of Kansas School of MedicineChief Residency, Internal Medicine, 2001 - 2002
University of Kansas School of MedicineResidency, Internal Medicine, 1999 - 2001
Baroda Medical CollegeClass of 1997

Certifications & Licensure

MO State Medical License 2021 - 2025
KS State Medical License 2001 - 2024
American Board of Internal Medicine Medical Oncology

Clinical Trials

Lapatinib in Women With Metastatic Breast Cancer Who Have Failed Prior Antihormone Therapy Start of enrollment: 2009 Mar 01
Terminated
Phase 2
Anti-Hormone Therapy (With Anastrazole and Fulvestrant) Before Surgery to Treat Postmenopausal Women With Breast Cancer. Start of enrollment: 2009 May 01
Completed
Phase 2
Evaluate Trastuzumab Plus Standard Chemotherapy Given Before Surgery in Breast Cancer Patients With Low HER 2 Expression Start of enrollment: 2009 Jul 01
Completed
Phase 2
A Study to Look at the Combination of Chemotherapy, Trastuzumab and RAD001 in HER2 Positive Breast Cancer Start of enrollment: 2010 Jul 01
Withdrawn
Phase 2
Lapatinib and RAD-001 for HER2 Positive Metastatic Breast Cancer Start of enrollment: 2011 Feb 01
Unknown status
Phase 2
Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry Start of enrollment: 2011 Mar 22
Recruiting
Neoadjuvant Study of Two Platinum Regimens in Triple Negative Breast Cancer Start of enrollment: 2015 Jul 01
Completed
Phase 2
Alpelisib And Sacituzumab Govitecan For Treatment Of Breast Cancer Start of enrollment: 2022 Mar 28
Recruiting
Phase 1
Roles: Principal Investigator, Contact
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer Start of enrollment: 2023 Sep 15
Recruiting
Phase 3
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Horm...
Erica L Mayer, Yue Ren, Nikhil Wagle, Reshma Mahtani, Cynthia Ma, Angela DeMichele, Massimo Cristofanilli, Jane Meisel, Kathy D Miller, Yara Abdou, Elizabeth C Riley, ...> ;Journal of Clinical Oncology. 2024 Mar 21
Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer risk.
Daniel R Barnes, Jonathan P Tyrer, Joe Dennis, Goska Leslie, Manjeet K Bolla, Michael Lush, Amber M Aeilts, Kristiina Aittomäki, Nadine Andrieu, Irene L Andrulis, Hoda...> ;Medrxiv. 2024 Mar 4
1 citations
Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel.
Hagai Levi, Shai Carmi, Saharon Rosset, Rinat Yerushalmi, Aviad Zick, Tamar Yablonski-Peretz, , Qin Wang, Manjeet K Bolla, Joe Dennis, Kyriaki Michailidou, Michael Lus...> ;Journal of Medical Genetics. 2023 Nov 27
Image analysis-based tumor infiltrating lymphocytes measurement predicts breast cancer pathologic complete response in SWOG S0800 neoadjuvant chemotherapy trial.
Kristina A Fanucci, Yalai Bai, Vasiliki Pelekanou, Zeina A Nahleh, Saba Shafi, Sneha Burela, William E Barlow, Priyanka Sharma, Alastair M Thompson, Andrew K Godwin, D...> ;NPJ Breast Cancer. 2023 May 13
2 citations
Novel Prognostic Staging System for Patients With De Novo Metastatic Breast Cancer.
Jennifer K Plichta, Samantha M Thomas, Daniel F Hayes, Mariana Chavez-MacGregor, Kimberly Allison, Jennifer de Los Santos, Amy M Fowler, Armando E Giuliano, Priyanka S...> ;Journal of Clinical Oncology. 2023 May 10
8 citations
ctDNA and residual cancer burden are prognostic in triple-negative breast cancer patients with residual disease.
Shane R Stecklein, Bruce F Kimler, Rachel Yoder, Kelsey Schwensen, Joshua M Staley, Qamar J Khan, Anne P O'Dea, Lauren E Nye, Manana Elia, Jaimie Heldstab, Trisha Home...> ;NPJ Breast Cancer. 2023 Mar 6
14 citations
Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a randomised, double-blind, placebo...
Eve Rodler, Priyanka Sharma, William E Barlow, Julie R Gralow, Shannon L Puhalla, Carey K Anders, Lori Goldstein, Debu Tripathy, Ursa A Brown-Glaberman, Thu-Tam Huynh,...> ;The Lancet. Oncology. 2023 Feb 1
3 citations
Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry.
Stefanie H Mueller, Alvina G Lai, Maria Valkovskaya, Kyriaki Michailidou, Manjeet K Bolla, Qin Wang, Joe Dennis, Michael Lush, Zomoruda Abu-Ful, Thomas U Ahearn, Irene...> ;Genome Medicine. 2023 Jan 26
2 citations
Evaluation of the Sensitivity to Endocrine Therapy Index and 21-Gene Breast Recurrence Score in the SWOG S8814 Trial.
Corey W Speers, W Fraser Symmans, William E Barlow, Alex Trevarton, Stephanie The, Lili Du, James M Rae, Steven Shak, Rick Baehner, Priyanka Sharma, Lajos Pusztai, Gab...> ;Journal of Clinical Oncology. 2023 Apr 1
2 citations
Thymidine kinase activity levels in serum can identify HR+ metastatic breast cancer patients with a low risk of early progression (SWOG S0226).
Mattias Bergqvist, Adrian Nordmark, Amy Williams, Costanza Paoletti, William Barlow, Erin F Cobain, Rita S Mehta, Julie R Gralow, Gabriel N Hortobagyi, Kathy S Albain,...> ;Biomarkers. 2023 May 1
1 citations
Evolving perspectives on the treatment of HR+/HER2+ metastatic breast cancer.
Mark Pegram, Richard Pietras, Chau T Dang, Rashmi Murthy, Thomas Bachelot, Wolfgang Janni, Priyanka Sharma, Erika Hamilton, Cristina Saura> ;Therapeutic Advances in Medical Oncology. 2023 Jan 1
6 citations
Tumor-Derived Extracellular Vesicles as Complementary Prognostic Factors to Circulating Tumor Cells in Metastatic Breast Cancer.
Afroditi Nanou, Jieling Miao, Frank A W Coumans, Emily M Dolce, Elizabeth Darga, William Barlow, Jeffrey B Smerage, Costanza Paoletti, Andrew K Godwin, Lajos Pusztai, ...> ;JCO Precision Oncology. 2023 Jan 1
Time to Optimize Deescalation Strategies in Triple-Negative Breast Cancer?
Priyanka Sharma> ;Clinical Cancer Research. 2022 Nov 14
1 citations
Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers.
Dhawan, M. S., Hakkaart, C., Pearson, J., Marquart, L., Dennis, J., Wiggins, G., Barnes, D., Robinson, B., Mace, P., Aittomäki, K., Andrulis, I., Arun, B., Azzollini, ...> ;Communications Biology. 2022 Oct 6
28 citations
Biomarkers for Systemic Therapy in Metastatic Breast Cancer: ASCO Guideline Update.
N Lynn Henry, Mark R Somerfield, Zoneddy Dayao, Anthony Elias, Kevin Kalinsky, Lisa M McShane, Beverly Moy, Ben Ho Park, Kelly M Shanahan, Priyanka Sharma, Rebecca Sha...> ;Journal of Clinical Oncology. 2022 Sep 20
17 citations
Impact of low versus negative estrogen/progesterone receptor status on clinico-pathologic characteristics and survival outcomes in HER2-negative breast cancer.
Rachel Yoder, Bruce F Kimler, Joshua M Staley, Kelsey Schwensen, Yen Y Wang, Karissa Finke, Anne O'Dea, Lauren Nye, Manana Elia, Gregory Crane, Richard McKittrick, Rob...> ;NPJ Breast Cancer. 2022 Jul 11
13 citations
Evaluation of the Durability of the Immune Humoral Response to COVID-19 Vaccines in Patients With Cancer Undergoing Treatment or Who Received a Stem Cell Transplant.
Qamar J Khan, Cory R Bivona, Grace A Martin, Jun Zhang, Ben Liu, Jianghua He, Kevin H Li, Maggie Nelson, Stephen Williamson, Gary C Doolittle, Weijing Sun, Dinesh Pal ...> ;JAMA Oncology. 2022 Jul 1
3 citations
Prospective longitudinal study of kinetics of humoral response to one, two, or three doses of SARS-CoV-2 vaccine in hematopoietic cell transplant recipients.
Qamar J Khan, Cory R Bivona, Ben Liu, Maggie Nelson, Grace A Martin, Muhammad Umair Mushtaq, Priyanka Sharma, Natalie R Streeter, Marc Hoffmann, Gary C Doolittle, Cunc...> ;Bone Marrow Transplantation. 2022 Jun 1
11 citations
Exploring the Impact of the Obesity Paradox on Lung Cancer and Other Malignancies.
Lindsay Joyce Nitsche, Sarbajit Mukherjee, Kareena Cheruvu, Cathleen Krabak, Rohit Rachala, Kalyan Ratnakaram, Priyanka Sharma, Maddy Singh, Sai Yendamuri> ;Cancers. 2022 Mar 11
2 citations
Early-stage Triple-negative Breast Cancer: Time to Optimize Personalized Strategies.
Nour Abuhadra, Shane Stecklein, Priyanka Sharma, Stacy Moulder> ;The Oncologist. 2022 Feb 3
110 citations
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients.
Elias, A., Christina Yau, Marie Osdoit, Marieke van der Noordaa, Sonal Shad, Jane Wei, Diane de Croze, Anne-Sophie Hamy, Marick Laé, Fabien Reyal, Gabe S Sonke, Tessa ...> ;The Lancet. Oncology. 2022 Jan 1
7 citations
Evaluating Serum Thymidine Kinase 1 in Patients with Hormone Receptor-Positive Metastatic Breast Cancer Receiving First-line Endocrine Therapy in the SWOG S0226 Trial.
Costanza Paoletti, William E. Barlow, Erin F. Cobain, Mattias Bergqvist, Rita S. Mehta, Julie Gralow, Gabriel N. Hortobagyi, Kathy S. Albain, Lajos Pusztai, Priyanka S...> ;Clinical Cancer Research. 2021 Sep 14
23 citations
Serial single-cell genomics reveals convergent subclonal evolution of resistance as patients with early-stage breast cancer progress on endocrine plus CDK4/6 therapy
Jason I. Griffiths, Jinfeng Chen, Patrick A. Cosgrove, Anne O'Dea, Priyanka Sharma, Cynthia X. Ma, Meghna S. Trivedi, Kevin Kalinsky, Kari B. Wisinski, Ruth O'Regan, I...> ;Nature Cancer. 2021 Jun 3
Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.
Juliette Coignard, Michael Lush, Jonathan Beesley, Tracy A. O'Mara, Joe Dennis, Jonathan Tyrer, Daniel R. Barnes, Lesley McGuffog, Goska Leslie, Manjeet K. Bolla, Muri...> ;Nature Communications. 2021 May 14
20 citations
Neoadjuvant endocrine therapy use in early stage breast cancer during the covid-19 pandemic.
Ko Un Park, Megan E. Gregory, Joey Bazan, Maryam B. Lustberg, Shoshana M. Rosenberg, Victoria S. Blinder, Priyanka Sharma, Lajos Pusztai, Chengli Shen, Ann H. Partridg...> ;Breast Cancer Research and Treatment. 2021 Mar 2
Join now to see all

Journal Articles

Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel
Amanda Amin, Jamie Wagner, Qamar J Khan, Roy A Jensen, Joshua M Mammen, Priyanka Sharma, Jennifer R Klemp, Clinical Cancer Research

Lectures

Results of randomized phase II trial of neoadjuvant carboplatin plus docetaxel or carboplatin plus paclitaxel followed by AC in stage I-III triple-negative breast canc...
2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

Summing It Up: Neoadjuvant Therapy in Triple-Negative DiseaseApril 6th, 2023
Focus on Optimizing Use of CDK4/6 Inhibitors in Metastatic HR+ Breast CancerMarch 8th, 2023
Addition of Veliparib to Cisplatin in Advanced Triple-Negative Breast Cancer with BRCA-like and Non–BRCA-like PhenotypeJanuary 23rd, 2023
Join now to see all